Cel-Sci Corporation (CVM): Price and Financial Metrics

Cel-Sci Corporation (CVM)

Today's Latest Price: $12.28 USD

0.21 (-1.68%)

Updated Nov 24 8:00pm

Add CVM to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 369 in Miscellaneous

See all "A" rated Strong Buy stocks

CVM Stock Summary

  • Cel Sci Corp's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 10.75% of US listed stocks.
  • CVM's went public 29.14 years ago, making it older than 83% of listed US stocks we're tracking.
  • CVM's price/sales ratio is 710.32; that's higher than the P/S ratio of 99.1% of US stocks.
  • Stocks that are quantitatively similar to CVM, based on their financial statements, market capitalization, and price volatility, are ORGS, AMBA, WATT, IMAB, and IPHI.
  • CVM's SEC filings can be seen here. And to visit Cel Sci Corp's official web site, go to cel-sci.com.

CVM Stock Price Chart Interactive Chart >

Price chart for CVM

CVM Price/Volume Stats

Current price $12.28 52-week high $18.00
Prev. close $12.49 52-week low $6.35
Day low $12.00 Volume 449,893
Day high $12.90 Avg. volume 756,175
50-day MA $13.07 Dividend yield N/A
200-day MA $13.21 Market Cap 474.30M

CVM Latest News Stream

Event/Time News Detail
Loading, please wait...

CVM Latest Social Stream

Loading social stream, please wait...

View Full CVM Social Stream

Latest CVM News From Around the Web

Below are the latest news stories about Cel Sci Corp that investors may wish to consider to help them evaluate CVM as an investment opportunity.

CEL-SCI Corporation Issues Letter to Shareholders

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation issues letter to shareholders.

Business Wire | September 15, 2020

CEL-SCI Corporation to Present at H.C. Wainwright 22nd Annual Global Investment Conference

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation to Present at H.C. Wainwright 22nd Annual Global Investment Conference

Business Wire | September 11, 2020

Cel-Sci up 5% on positive data on COVID-19 conjugates

CEL-SCI ([[CVM]] +4.7%) bucks the broad market's softness, albeit on below-average volume, after reporting encouraging results from animal studies on its LEAPS COVID-19 conjugates that, it says, showed faster and "much higher than expected" antibody responses against a non-mutating region of SARS-CoV-2 after only one injection. IgG antibody response was...

Seeking Alpha | July 24, 2020

CEL-SCI Announces Early Results with COVID 19 LEAPS Vaccine/Treatment

CEL-SCI Announces Early Results with COVID 19 LEAPS Vaccine/Treatment.

Yahoo | July 24, 2020

We Think CEL-SCI (NYSEMKT:CVM) Needs To Drive Business Growth Carefully

We can readily understand why investors are attracted to unprofitable companies. Indeed, CEL-SCI (NYSEMKT:CVM) stock...

Yahoo | July 16, 2020

Read More 'CVM' Stories Here

CVM Price Returns

1-mo -5.03%
3-mo -10.17%
6-mo -7.88%
1-year 63.95%
3-year 553.19%
5-year 4.51%
YTD 34.21%
2019 218.82%
2018 51.85%
2017 8.00%
2016 -81.08%
2015 -36.21%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.9344 seconds.